Bank Of Montreal Bei Gene, Ltd. Transaction History
Bank Of Montreal
- $197 Billion
- Q2 2024
A detailed history of Bank Of Montreal transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Bank Of Montreal holds 10,031 shares of BGNE stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,031
Previous 10,016
0.15%
Holding current value
$2.25 Million
Previous $1.57 Million
8.62%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BGNE
# of Institutions
212Shares Held
45.1MCall Options Held
106KPut Options Held
93.1K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.37 Billion20.04% of portfolio
-
Capital International Investors Los Angeles, CA7.01MShares$1.57 Billion0.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$1.16 Billion19.1% of portfolio
-
Primecap Management CO Pasadena, CA4.99MShares$1.12 Billion0.52% of portfolio
-
Baillie Gifford & CO3.68MShares$827 Million0.42% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23.3B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...